Skip to main content

Table 2 Lesion and procedural characteristics

From: Effects of daily glucose fluctuations on the healing response to everolimus-eluting stent implantation as assessed using continuous glucose monitoring and optical coherence tomography

  Overall (n = 60) DM (n = 37) Non-DM (n = 23) P value (DM vs. non-DM)
Lesion location     0.72
 LAD 26 (43.3) 15 (40.5) 11 (47.8)  
 LCx 15 (25.0) 9 (24.3) 6 (26.1)  
 RCA 19 (31.2) 13 (35.1) 6 (26.1)  
AHA/ACC lesion classification     0.27
 Type A/B1 12 (20.0) 6 (16.2) 6 (26.1)  
 Type B2/C 48 (80.0) 31 (83.8) 17 (73.9)  
 Chronic total occlusion 8 (13.3) 6 (16.2) 2 (8.7) 0.34
 Bifurcation 16 (26.7) 9 (24.3) 7 (30.4) 0.60
IVUS measurements before stenting
 Plaque volume
  Absolute data (mm3) 98.1 ± 67.7 104.0 ± 77.3 89.2 ± 50.7 0.48
  Plaque burden (%) 58.1 ± 10.5 57.4 ± 11.7 59.2 ± 8.4 0.62
 Lesion length (mm) 14.4 ± 9.1 14..7 ± 10.3 14.0 ± 7.1 0.81
Fibrous
 Absolute data (mm3) 35.1 ± 25.8 37.6 ± 29.0 31.4 ± 20.3 0.44
 Relative data (%) 60.4 ± 9.2 60.6 ± 10.0 59.9 ± 8.2 0.80
Fibro-fatty
 Absolute data (mm3) 7.3 ± 5.5 7.8 ± 6.3 6.5 ± 4.0 0.41
 Relative data (%) 12.7 ± 5.2 12.1 ± 3.8 13.6 ± 6.8 0.37
Dense-calcium
 Absolute data (mm3) 5.2 ± 5.4 5.5 ± 6.1 4.7 ± 4.2 0.61
 Relative data (%) 7.7 ± 6.0 7.4 ± 5.8 8.3 ± 6.5 0.64
Necrotic-core
 Absolute data (mm3) 12.9 ± 12.4 14.4 ± 14.1 10.7 ± 9.4 0.34
 Relative data (%) 19.1 ± 5.3 19.8 ± 4.6 18.2 ± 6.1 0.33
Procedural characteristics
 Stent length (mm) 27.2 ± 13.7 30.2 ± 15.8 22.3 ± 7.4 0.011
 Stent size (mm) 3.0 ± 0.4 2.9 ± 0.4 3.1 ± 0.4 0.14
 Maximum inflation pressure (atm) 11.1 ± 1.4 11.2 ± 1.3 11.0 ± 1.6 0.55
 Overlap stenting 11 (18.3) 10 (27.0) 1 (4.3) 0.026
 Post-dilatation 47 (78.3) 27 (73.0) 20 (87.0) 0.17
 Rotablation 6 (10.0) 5 (13.5) 1 (4.3) 0.25
  1. Values are mean ± standard deviation or number (%)
  2. AHA/ACC American Heart Association/American College of Cardiology, IVUS intravascular ultrasound, LAD left anterior descending artery, LCx left circumflex artery, RCA right coronary artery